Review: Eradication of Helicobacter pylori to prevent gastroduodenal diseases: Hitting more than one bird with the same stone

Therapeutic Advances in Gastroenterology

Volumn 1, Issue 2, 2008, Pages 111-120

  Lee, Yi Chia ^a   Liou, Jyh Ming ^a   Wu, Chun Ying ^b   Lin, Jaw Town ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b Veteran General Hospital   (Taiwan)

Author keywords

eradication; gastric cancer; Helicobacter pylori; nonulcer dyspepsia; peptic ulcer; prevention

Indexed keywords

EID: 84993705015     PISSN: 1756283X     EISSN: None     Source Type: Journal    
DOI: 10.1177/1756283X08094880     Document Type: Review

References (85)

1. Adamsson, I.,Nord, C.E.,Lundquist, P.,Sjöstedt, S. and Edlund, C. (1999)Comparative effects of omeprazole, amoxycillin plus metronidazole versus omeprazole, clarithromycin plus metronidazole on the oral, gastric and intestinal microflora in Helicobacter pylori-infected patients. J Antimicrob Chemother 44: 629-640.
2. Andersson, S.I.,Hovelius, B.,Molstad, S. and Wadstrom, T. (1994)Dyspepsia in general practice: psychological findings in relation to Helicobacter pylori serum antibodies. Journal of Psychosomatic Research 38: 241-247.
3. Blaser, M.J.,Chen, Y. and Reibman, J. (2008)Does Helicobacter pylori protect against asthma and allergy ? Gut 57: 561-567.
4. Cars, O.,Mölstad, S. and Melander, A. (2001)Variation in antibiotic use in the European Union. Lancet 357: 1851-1853.
5. Chow, W.H.,Blaser, M.J.,Blot, W.J.,Gammon, M.D.,Vaughan, T.L.,Risch, H.A.et al. (1998)An inverse relation between CagA+ strains of Helicobacter pylori infection and risk of esophageal gastric cardia adenocarcinoma. Cancer Res 58: 588-590.
6. de Vries, A.C.,van Grieken, N.C.,Looman, C.W.,Casparie, M.K.,de Vries, E.,Meijer, G.A.et al. (2008)Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands. Gastroenterology 134: 945-952.
7. Dobrilla, G.,Zancanella, L. and Amplatz, S. (1993)The need for long-term treatment of peptic ulcer. Alimentary Pharmacology and Therapeutics 7(Suppl 2): 3-15.
8. Dixon, M.F. (2001) Pathology of gastritis and peptic ulceration. InMobley, H.L.T.,Mendz, G.L. and Hazell, S.L.(eds) Helicobacter pylori: physiology and genetics. Washington, D.C.ASM Press, 459-469.
9. Ena, J.,Lopez-Perezagua, M.M.,Martinez-Peinado, C.,Cia-Barrio, M.A.,Ruíz-López, I.et al. (1998)Emergence of ciprofloxacin resistance in Escherichia coli isolates after widespread use of fluoroquinolones. Diagn Microbiol Infect Dis 30: 103-107.
10. Feldman, R.A. (2001) Epidemiologic observations and open questions about disease and infection caused by Helicobacter pylori. InAchtman, M. and Suerbaum, S.(eds) Helicobacter pylori: molecular and cellular biology.Wymondham, United Kingdom, Horizon Scientific Press, 29-51.
11. Fendrick, A.M.,Chernew, M.E.,Hirth, R.A.,Bloom, B.S.,Bandekar, R.R. and Scheiman, J.M. (1999)Clinical and economic effects of population-based Helicobacter pylori screening to prevent gastric cancer. Arch Intern Med 159: 142-148.
12. Ford, A.C.,Delaney, B.C.,Forman, D. and Moayyedi, P. (2004)Eradication therapy in Helicobacter pylori positive peptic ulcer disease: systematic review and economic analysis. Am J Gastroenterol 99: 1833-1855.
13. Ford, A.C.,Delaney, B.C.,Forman, D. and Moayyedi, P. (2006)Eradication therapy for peptic ulcer disease in Helicobacter pylori positive patients. Cochrane Database Syst Rev 2: CD 003840.
14. Forman, D.,Newell, D.G.,Fullerton, F.,Yarnell, J.W.,Stacey, A.R.,Wald, N.et al. (1991)Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. BMJ 302: 1302-1305.
15. Gisbert, J.P. (2005)The recurrence of Helicobacter pylori infection: incidence and variables influencing it. A critical review. Am J Gastroenterol 100: 2083-2099.
16. Glupczynski, Y.,Mégraud, F.,Lopez-Brea, M. and Andersen, L.P. (2001)European multicentre survey of in vitro antimicrobial resistance in Helicobacter pylori. Eur J Clin Microbiol Infect Dis 20: 820-823.
17. Graham, D.Y. and Shiotani, A. (2005)The time to eradicate gastric cancer is now. Gut 54: 735-738.
18. Granizo, J.J.,Aguilar, L.,Casal, J.,García-Rey, C.,Dal-Ré, R. and Baquero, F. (2000)Streptococcus pneumoniae resistance to erythromycin and penicillin in relation to macrolide and beta-lactam consumption in Spain (1979-1997). J Antimicrob Chemother 46: 767-773.
19. Gulbinovic, J.,Myrback, K.E.,Bytautiene, J.,Wettermark, B.,Struwe, J. and Bergman, U. (2001)Marked differences in antibiotic use and resistance between university hospitals in Vilnius, Lithuania, and Huddinge, Sweden. Microb Drug Resist 7: 383-389.
20. Harris, R.A.,Owens, D.K.,Witherell, H. and Parsonnet, J. (1999)Helicobacter pylori and gastric cancer: what are the benefits of screening only for the cagA phenotype of H. pylori?. Helicobacter 4: 69-76.
21. Harthug, S.,Jureen, R.,Mohn, S.C.,Högel, J. and Trautmann, M. (2002)Norwegian enterococcal study group. The prevalence of faecal carriage of ampicillin-resistant and high-level gentamicin-resistant enterococci among inpatients at 10 major Norwegian hospitals. J Hosp Infect 50: 145-154.
22. Hopkins, R.J.,Girardi, L.S. and Turney, E.A. (1996)Relationship between Helicobacter pylori eradication and reduced duodenal and gastric ulcer recurrence: a review. Gastroenterology 1996; 110: 1244-1252.
23. Hsu, P.I.,Lai, K.H.,Tseng, H.H.,Lo, G.H.,Lo, C.C.,Lin, C.K.et al. (2001)Eradication of Helicobacter pylori prevents ulcer development in patients with ulcer-like functional dyspepsia. Aliment Pharmacol Ther 15: 195-201.
24. Huang, J.Q.,Sridhar, S. and Hunt, R.H. (2002)Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis. Lancet 359: 14-22.
25. Ikenberry, S.O.,Harrison, M.E.,Lichtenstein, D.,Dominitz, J.A.,Anderson, M.A.,Jagannath, S.B.et al. (2007)The role of endoscopy in dyspepsia. Gastrointest Endosc 66: 1071-1075.
26. Imperiale, T.F.,Speroff, T.,Cebul, R.D. and McCullough, A.J. (1995)A cost analysis of alternative treatments for duodenal ulcer. Ann Int Med 123: 665-672.
27. Jaakkimainen, R.L.,Boyle, E. and Tudiver, F. (1999)Is Helicobacter associated with non-ulcer dyspepsia and will eradication improve symptoms? A meta-analysis. British Medical Journal 319: 1040-1044.
28. Kato, M.,Asaka, M.,Ono, S.,Nakagawa, M.,Nakagawa, S.,Shimizu, Y.et al. (2007)Eradication of Helicobacter pylori for primary gastric cancer and secondary gastric cancer after endoscopic mucosal resection. J Gastroenterol 42(Suppl 17): 16-20.
29. Kuipers, E.J.,Thijs, J.C. and Festen, H.P. (1995)The prevalence of Helicobacter pylori in peptic ulcer disease. Aliment Pharmacol Ther 9 (Suppl 2): 59-69.
30. Laheij, R.J.,Jansen, J.B.,van de Lisdonk, E.H.,Severens, J.L. and Verbeek, A.L. (1996)Review article: symptom improvement through eradication of Helicobacter pylori in patients with non-ulcer dyspepsia. Alimentary Pharmacology and Therapeutics 10: 843-850.
31. Laine, L.A. (1996)Helicobacter pylori and complicated ulcer disease. Am J Med 100(5A): 52S-57S.
32. Lam, S.K. and Talley, N.J. (1998)Report of the 1997 Asia Pacific Consensus Conference on the management of Helicobacter pylori infection. J Gastroenterol Hepatol 13: 1-12.
33. Lane, J.A.,Murray, L.J.,Noble, S.,Egger, M.,Harvey, I.M.,Donovan, J.L.et al. (2006)Impact of Helicobacter pylori eradication on dyspepsia, health resource use, and quality of life in the Bristol Helicobacter project: randomized controlled trial. BMJ 332: 199-204.
34. Lee, C.W.,Rickman, B.,Rogers, A.B.,Ge, Z.,Wang, T.C. and Fox, J.G. (2008)Helicobacter pylori eradication prevents progression of gastric cancer in hypergastrinemic INS-GAS mice. Cancer Res 68: 3540-3548.
35. Lee, Y.C.,Lin, J.T.,Wu, H.M.,Liu, T.Y.,Yen, M.F.,Chiu, H.M.et al. (2007)Cost-effectiveness analysis between primary and secondary preventive strategies for gastric cancer. Cancer Epidemiol Biomarkers Prev 16: 875-885.
36. Leodolter, A.,Kulig, M.,Brasch, H.,Meyer-Sabellek, W.,Willich, S.N. and Malfertheiner, P. (2001)A meta-analysis comparing eradication, healing and relapse rates in patients with Helicobacter pylori-associated gastric or duodenal ulcer. Aliment Pharm Ther 15: 1949-1958.
37. Lepper, P.M.,Grusa, E.,Reichl, H.,Högel, J. and Trautmann, M. (2002)Consumption of imipenem correlates with beta-lactam resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother 46: 2920-2925.
38. Lin, J.T.,Wang, L.Y.,Wang, J.T.,Wang, T.H.,Yang, C.S. and Chen, C.J. (1995)A nested case-control study on the association between Helicobacter pylori infection and gastric cancer risk in a cohort of 9775 men in Taiwan. Anticancer Res 15: 603-606.
39. Liou, J.M.,Lin, J.T.,Wang, H.P.,Huang, S.P.,Lee, Y.C.,Shun, C.T.et al. (2005)The optimal age threshold for screening upper endoscopy for uninvestigated dyspepsia in Taiwan, an area with a higher prevalence of gastric cancer in young adults. Gastrointest Endosc 61: 819-825.
40. Lochhead, P. and El-Omar, E.M. (2007)Helicobacter pylori infection and gastric cancer. Best Pract Res Clin Gastroenterol 21: 281-297.
41. Loffeld, R.J.,Potters, H.V.,Stobberingh, E.,Flendrig, J.A.,van Spreeuwel, J.P. and Arends, J.W. (1989)Campylobacter associated gastritis in patients with non-ulcer dyspepsia: a double blind placebo controlled trial with colloidal bismuth subcitrate. Gut 30: 1206-1212.
42. Malfertheiner, P.,Sipponen, P.,Naumann, M.,Moayyedi, P.,Mégraud, F.,Xiao, S.D.et al. (2005)H. pylori-Gastric Cancer Task Force. Helicobacter pylori eradication has the potential to prevent gastric cancer: a state-of-the-art critique. Am J Gastroenterol 100: 2100-2115.
43. Malfertheiner, P.,Megraud, F.,O'Morain, C.,Bazzoli, F.,El-Omar, E.,Graham, D.et al. (2007)Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut 56: 772-781.
44. Moayyedi, P.,Feltbower, R.,Brown, J.,Mason, S.,Mason, J.,Nathan, J.et al. (2000)Effect of population screening and treatment for Helicobacter pylori on dyspepsia and quality of life in the community: a randomized controlled trial. Leeds HELP Study Group. Lancet 355: 1665-1669.
45. Moayyedi, P.,Soo, S.,Deeks, J.,Delaney, B.,Harris, A.,Innes, M.et al. (2006)Eradication of Helicobacter pylori for non-ulcer dyspepsia. Cochrane Database Syst Rev 19: CD002096.
46. Nomura, A.,Stemmermann, G.N.,Chyou, P.H.,Kato, I.,Perez-Perez, G.I. and Blaser, M.J. (1991)Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med 325: 1132-1136.
47. Ofman, J.,Wallace, J.,Badamgarav, E.,Chiou, C.F.,Henning, J. and Laine, L. (2002)The cost-effectiveness of competing strategies for the prevention of recurrent peptic ulcer hemorrhage. Am J Gastroenterol 97: 1941-1950.
48. Papatheodoridis, G.V. and Archimandritis, A.J. (2005)Role of Helicobacter pylori eradication in aspirin or non-steroidal anti-inflammatory drug users. World J Gastroenterol 11: 3811-3816.
49. Parsonnet, J.,Friedman, G.D.,Vandersteen, D.P.,Chang, Y.,Vogelman, J.H.,Orentreich, N.et al. (1991)Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 325: 1127-1131.
50. Parsonnet, J.,Hansen, S.,Rodriguez, L.,Gelb, A.B.,Warnke, R.A.,Jellum, E.et al. (1994)Helicobacter pylori infection and gastric lymphoma. N Engl J Med 330: 1267-1271.
51. Parsonnet, J.,Harris, R.A.,Hack, H.M. and Owens, D.K. (1996)Modelling cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer: a mandate for clinical trials. Lancet 348: 150-154.
52. Peek, R.M. and Blaser, M.J. (2002)Helicobacter pylori and gastrointestinal adenocarcinoma. Nat Rev Cancer 2: 28-37.
53. Penston, J.G. (1993)A decade of experience with long-term continuous treatment of peptic ulcers with H2-receptor antagonists. Alimentary Pharmacology and Therapeutics 7(Suppl 2): 27-33.
54. Perez Aldana, L.,Kato, M.,Nakagawa, S.,Kawarasaki, M.,Nagasako, T.,Mizushima, T.et al. (2002)The relationship between consumption of antimicrobial agents and the prevalence of primary Helicobacter pylori resistance. Helicobacter 7: 306-309.
55. Raghunath, A.,Hungin, A.P.,Wooff, D. and Childs, S. (2003)Prevalence of Helicobacter pylori in patients with gastro-oesophageal reflux disease: systematic review. BMJ 326:737.
56. Roderick, P.,Davies, R.,Raftery, J.,Crabbe, D.,Pearce, R.,Patel, P.et al. (2003)Cost-effectiveness of population screening for Helicobacter pylori in preventing gastric cancer and peptic ulcer disease, using simulation. J Med Screen 10: 148-156.
57. Romero-Gallo, J.,Harris, E.J.,Krishna, U.,Washington, M.K.,Perez-Perez, G.I.,Peek and R.M.Jr. (2008)Effect of Helicobacter pylori eradication on gastric carcinogenesis. Lab Invest 88: 328-336.
58. Rowland, M.,Kumar, D.,Daly, L.,O'Connor, P.,Vaughan, D. and Drumm, B. (1999)Low rates of Helicobacter pylori reinfection in children. Gastroenterology 117: 336-341.
59. Sonnenberg, A. and Everhart, J.E. (1997)Health impact of peptic ulcer in the United States. Am J Gastroenterol 92: 614-620.
60. Suerbaum, S. and Michetti, P. (2002)Helicobacter pylori infection. N Engl J Med 347: 1175-1186.
61. Schlemper, R.J.,van der Werf, S.D.,Biemond, I. and Lamers, C.B. (1996) Seroepidemiology of gastritis in Japanese and Dutch male employees with and without ulcer disease. Eur J Gastroenterol Hepatol 8: 33-39.
62. Sjolund, M.,Wreiber, K.,Andersson, D.I.,Blaser, M.J. and Engstrand, L. (2003)Long-term persistence of resistant Enterococcus species after antibiotics to eradicate Helicobacter pylori. Ann Intern Med 139: 483-487.
63. Spiegel, B.M.,Vakil, N.B. and Ofman, J.J. (2002)Dyspepsia management in primary care: a decision analysis of competing strategies. Gastroenterology 122: 1270-1285.
64. Sung, J.J.,Lin, S.R.,Ching, J.Y.,Zhou, L.Y.,To, K.F.,Wang, R.T.et al. (2000)Atrophy and intestinal metaplasia one year after cure of H. pylori infection: a prospective, randomized study. Gastroenterology 119:7.
65. Tack, J.,Talley, N.J.,Camilleri, M.,Holtmann, G.,Hu, P.,Malagelada, J.R.et al. (2006)Functional gastroduodenal disorders. Gastroenterology 130: 1466-1479.
66. Talley, N.J.,Silverstein, M.D.,Agreus, L.,Nyren, O.,Sonnenberg, A.,Holtmann, G.et al. (1998)AGA technical review: evaluation of dyspepsia. American Gastro-enterological Association. Gastroenterology 114: 582-595.
67. Talley, N.J.,Vakil, N.B. and Moayyedi, P. (2005)American gastroenterological association technical review on the evaluation of dyspepsia. Gastroenterology 129: 1756-1780.
68. Trespi, E.,Broglia, F.,Villani, L.,Luinetti, O.,Fiocca, R. and Solcia, E. (1994)Distinct profiles of gastritis in dyspepsia subgroups. Their different clinical responses to gastritis healing after Helicobacter pylori eradication. Scandinavian Journal of Gastroenterology 29: 884-888.
69. Tytgat, G.N.,Lee, A.,Graham, D.Y.,Dixon, M.F. and Rokkas, T. (1993)The role of infectious agents in peptic ulcer disease. Gastroenterology International 6: 76-89.
70. Tytgat, G.N. (1998)Treatment of peptic ulcer. Digestion 59: 446-452.
71. Tytgat, G.N. (2002)Role of endoscopy and biopsy in the work up of dyspepsia. Gut 50 (Suppl 4): 13-16.Uemura, N.,Mukai, T.,Okamoto, S.,Yamaguchi, S.,Mashiba, H.,Taniyama, K.et al. (1997 )Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer. Cancer Epidemiol Biomarkers Prev 6: 639–642.
72. Uemura, N. and Okamoto, S. (2000)Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer in Japan. Gastroenterol Clin North Am 29: 819-827.
73. Uemura, N.,Okamoto, S.,Yamamoto, S.,Matsumura, N.,Yamaguchi, S.,Yamakido, M.et al. (2001)Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 345: 784-789.
74. van der Hulst, R.W.,Rauws, E.A.,Köycü, B.,Keller, J.J.,Bruno, M.J.,Tijssen, J.G.et al. (1997)Prevention of ulcer recurrence after eradication of Helicobacter pylori: a prospective long-term follow-up study. Gastroenterology 113: 1082-1086.
75. Vergara, M.,Catalán, M.,Gisbert, J.P. and Calvet, X. (2005)Meta-analysis: role of Helicobacter pylori eradication in the prevention of peptic ulcer in NSAID users. Aliment Pharmacol Ther 21: 1411-1418.
76. Wai, C.T.,Yeoh, K.G.,Ho, K.Y.,Kang, J.Y. and Lim, S.G. (2002)Diagnostic yield of upper endoscopy in Asian patients presenting with dyspepsia. Gastrointest Endosc 56: 548-551.
77. Wang, Q.,Jin, P.H.,Lin, G.W.,Xu, S.R. and Chen, J. (2003)Cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer: Markov decision analysis. Zhonghua Liu Xing Bing Xue Za Zhi 24: 135-139.
78. Watanabe, T.,Tada, M.,Nagai, H.,Sasaki, S. and Nakao, M. (1998)Helicobacter pylori infection induces gastric cancer in mongolian gerbils. Gastroenterology 115: 642-648.
79. Williams, B.,Luckas, M.,Ellingham, J.H.,Dain, A. and Wicks, A.C. (1988)Do young patients with dyspepsia need investigation? Lancet 2: 1349-1351.
80. Wong, B.C.,Lam, S.K.,Wong, W.M.,Chen, J.S.,Zheng, T.T.,Feng, R.E.et al. (2004)Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA 291: 187-194.
81. Wotherspoon, A.C. (1998)Helicobacter pylori infection and gastric lymphoma. Br Med Bull 54: 79-85.
82. Wu, A.H.,Crabtree, J.E.,Bernstein, L.,Hawtin, P.,Cockburn, M.,Tseng, C.C.et al. (2003)Role of Helicobacter pylori Cag A+ strains and risk of adenocarcinoma of the stomach and esophagus. Int J Cancer 103: 815-821.
83. Wu, M.S.,Chen, C.J. and Lin, J.T. (2005)Host-environment interactions: their impact on progression from gastric inflammation to carcinogenesis and on development of new approaches to prevent and treat gastric cancer. Cancer Epidemiol Biomarkers Prev 14: 1878-1882.
84. Wyatt, J.I.,Rathbone, B.J.,Sobala, G.M.,Shallcross, T.,Heatley, R.V.,Axon, A.T.et al. (1990)Gastric epithelium in the duodenum: its association with Helicobacter pylori and inflammation. Journal of Clinical Pathology 43: 981-986.
85. Ye, W.,Held, M.,Lagergren, J.,Engstrand, L.,Blot, W.J.,McLaughlin, J.K.et al. (2004)Helicobacter pylori infection and gastric atrophy: risk of adenocarcinoma and squamous cell carcinoma of the esophagus and adenocarcinoma of the gastric cardia. J Natl Cancer Inst 96: 396-402.